Method for treating or preventing a pancreatic dysfunction

Details for Australian Patent Application No. 2009317874 (hide)

Owner Angioblast Systems, Inc.

Inventors Itescu, Silviu; Krishnan, Ravi

Agent FB Rice

Pub. Number AU-A-2009317874

PCT Pub. Number WO2010/057260

Priority 61/199,796 20.11.08 US

Filing date 19 November 2009

Wipo publication date 27 May 2010

International Classifications

C12N 5/077 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 35/39 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 5/48 (2006.01) Drugs for disorders of the endocrine system

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/057260 Priority application(s): WO2010/057260

12 April 2012 Alteration of Name

  The name of the applicant has been altered to Mesoblast, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009317875-Utilisation of desalination waste

2009317870-A clamp and wrapping assembly for patching a pipe rupture